Ceapro Inc.
CRPOF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $786 | $725 | $1,265 | $1,546 |
| - Cash | $5 | $9 | $11 | $11 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $783 | $718 | $1,256 | $1,537 |
| Revenue | $3 | $2 | $3 | $2 |
| % Growth | 68% | -37% | 40.1% | – |
| Gross Profit | $1 | $0 | $1 | $1 |
| % Margin | 38.3% | 5.9% | 41.2% | 57.3% |
| EBITDA | -$2 | -$2 | -$1 | -$1 |
| % Margin | -69.7% | -127.2% | -34% | -48.1% |
| Net Income | -$2 | -$2 | -$1 | -$1 |
| % Margin | -68.1% | -129% | -39.7% | -61.8% |
| EPS Diluted | -0.024 | -0.027 | -0.013 | -0.015 |
| % Growth | 11.4% | -104.5% | 10.1% | – |
| Operating Cash Flow | -$3 | -$2 | $0 | -$1 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$2 | $0 | -$1 |